Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.31, Iss.3, 2011-04, pp. : 249-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Life-threatening bleeding under vitamin K antagonists in spite of an INR in the therapeutic range

By Gavillet Mathilde

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 2, 2011-08 ,pp. : 232-237

Springer Publishing Company

Access to resources Recommend Favorite

NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?

Recent Patents on Cardiovascular Drug Discovery, Vol. 10, Iss. 1, 2015-04 ,pp. : 60-64

Bentham Science Publishers

Access to resources Recommend Favorite

Quality Assessment of Anticoagulation Dose Management: Comparative Evaluation of Measures of Time-in-Therapeutic Range

By Schmitt L. Speckman J. Ansell J.

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 3, 2003-06 ,pp. : 213-216

Springer Publishing Company

Access to resources Recommend Favorite

Quality of Anticoagulation With Vitamin K Antagonists

Clinical Cardiology, Vol. 38, Iss. 6, 2015-06 ,pp. : 357-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 3, 2015-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite